The selected article could not be found. Try again later or contact administrator.
The doctor will see you now (from the other side of the world)
Features
The doctor will see you now (from the other side of the world)
Updated with video
3 COMMENTS - Feb 10, 2012 12:30 EST
A unique "medical mission" using handheld echo in a remote rural population in India is being hailed as a success after cardiologists around the globe logged on over a two-day period to read the echocardiograms of unseen patients half a world away.
Lipid/Metabolic
Over 1300 deaths in Mediator scandal in France
Feb 9, 2012 14:15 EST
The number of deaths attributable to heart-valve insufficiency as a result of the use of benfluorex in France is likely more than double that previously thought, a new investigation finds.
Acute Coronary Syndromes
TRA 2°P: Vorapaxar meets end point but ups bleeding
Feb 7, 2012 12:20 EST
In its second phase 3 trial, Merck's novel antiplatelet agent reduced ischemic events but increased bleeding, including ICH. Results looked more promising in patients without a history of stroke.
heartbriefs
heartbriefs
View all »

Editorial series

Debate and dialogue between top cardiovascular specialists, produced by theheart.org's editorial team
Life and times of leading cardiologists with Rob Califf. Guest: Martin Leon
Editorial series
Life and times of leading cardiologists with Rob Califf. Guest: Martin Leon
1 COMMENT - Feb 7, 2012 09:00 EST
Dr Martin Leon talks about his decision to become a doctor at age six, how the death of his mother led him to interventional cardiology, and the genesis of the internationally renowned TCT meetings.
Antithrombotic therapies in ACS: An update from Europe
Editorial series
Antithrombotic therapies in ACS: An update from Europe
Jan 30, 2012 10:30 EST
Drs Jean-Pierre Bassand, Peter Clemmensen, and Jean-Philippe Collet review the latest data on antithrombotic therapies in ACS. Hear the European perspective on antiplatelet therapy, anticoagulation agents, and anticoagulants in the setting of primary PCI.
European perspectives on CRT therapy: An update for 2012
Editorial series
European perspectives on CRT therapy: An update for 2012
1 COMMENT - Jan 24, 2012 08:59 EST
Drs Cecilia Linde and Pierre Bordachar discuss the latest trial findings in CRT and the implications for research, practice, and patient outcomes in 2012.
Salt, hypertension, and prevention
Editorial series
Salt, hypertension, and prevention
8 COMMENTS - Jan 16, 2012 08:24 EST
Dr Bob Harrington talks to Drs Michael Alderman and Lawrence Appel about the challenges in understanding the role of salt in cardiovascular disease and why it is such a controversial topic.
Discussion and opinions
A fresh take on current cardiology affairs by theheart.org contributors

Topolog by Dr Eric Topol
Topolog
Talking about a (healthcare) revolution: The digital age ushers in precision medicine
7 comments
Jan 25, 2012 11:25 EST
The digital age is revolutionizing the healthcare paradigm by replacing an archaic and wasteful population-based model with precision medicine.
Most recent posts
theheart.org forum theheart.org forum
Exchanges among healthcare providers, clinicians, and researchers
Visit the forum »
Arrhythmia/EP
Fidelis failures climb: "Strongly consider" replacement at ICD change-out
Feb 10, 2012 17:00 EST
Heart failure
New mitral-repair therapies face obstacles
Feb 10, 2012 16:30 EST
Thrombosis
More hope for factor Xa reversal
1 COMMENT - Feb 10, 2012 14:00 EST
Thrombosis
US judge upholds FDA approval of generic enoxaparin
Feb 9, 2012 16:30 EST
Arrhythmia/EP
Referring MDs fall short on ICD-indication guidelines
Feb 9, 2012 12:15 EST
Medscape Medical News
Apixaban superior for AF patients with previous stroke, TIA
Feb 9, 2012 11:15 EST
Prevention
Like father, like son: Y-chromosome variant may explain CAD
Feb 8, 2012 18:30 EST
Interventional/Surgery
Wide variation in PCI for "unclear indications"
1 COMMENT - Feb 8, 2012 17:15 EST
Interventional/Surgery
PCI appropriateness criteria draw criticism
5 COMMENTS - Feb 8, 2012 16:45 EST
Arrhythmia/EP
More bleeding, thromboembolic events with dabigatran in AF ablation
Feb 8, 2012 16:45 EST
Brain/Kidney/Peripheral
For stroke risk, look for novel lipid/lipoprotein biomarkers
4 COMMENTS - Feb 8, 2012 11:15 EST
Most popular
  1. The flap over flavonoids
  2. PCI appropriateness criteria draw criticism
  3. "Valve-on-a-stick" transaortic TAVI offers alternative to transfemoral route
  4. TRA 2°P: Vorapaxar meets end point but ups bleeding
  5. "Tetherless" power-transmission technology could radically change LVAD therapy
  6. No recurrent stroke prevention seen with clopidogrel plus aspirin
  7. "Irrational" choices stall adoption of new antiplatelets
  8. Aspirin as effective as warfarin in heart failure: WARCEF
  9. Dr Robert Harrington leaves DCRI for Stanford University
  10. Apixaban superior for AF patients with previous stroke, TIA
View all news »
  1. What is happening in this tracing?
  2. What is the mechanism of aortic insufficiency for this 60-year-old man with a murmur?
  3. "Irrational" choices stall adoption of new antiplatelets
  4. Heart to Heart: Potential Impact of Optimal Implementation of Evidence-Based Heart Failure Therapi
  5. PCI appropriateness criteria draw criticism
  6. State-of-the-Art Care for Sudden Cardiac Arrest: Standardizing Care in the United States
  7. Not Your Mother's Cath Lab
  8. For stroke risk, look for novel lipid/lipoprotein biomarkers
  9. Cardiologists accused of defrauding Medicare by performing unnecessary cardiac procedures
  10. Aspirin as effective as warfarin in heart failure: WARCEF
View all discussions »
Membership is free!
Like us on FacebookFollow us on Twitter
Inside Themes
Interventional/Surgery
ACUTE MI
Featured program
Approach to Improve Strategies to Reduce Risk for SCA Post-PCI
RELEASE DATE: Sep 20, 2011
Arrhythmia/EP
AF Stroke Prevention
Featured program
A New Era in the Management of AF: An Update on Oral Anticoagulation
RELEASE DATE: Sep 27, 2011
Interventional/Surgery
Advances in Arterial Access
Featured program
Making Same-Day Discharge After PCI a Reality: What You Need to Know
RELEASE DATE: Dec 19, 2011
Acute Coronary Syndromes
Antiplatelet Therapies
Featured program
Testing the Trialist: Addressing the Platelet in ACS and PCI
RELEASE DATE: Sep 21, 2011
Interventional/Surgery
Cathether Based Therapies
Featured program
Minimizing Stroke in TAVI
RELEASE DATE: Oct 12, 2011
Hypertension
Comprehensive PAH Management
Featured program
Management of PAH: When and How to Use IV Agents
RELEASE DATE: Aug 31, 2011
Interventional/Surgery
Drug-Eluting Stents
Featured program
The Complex Case of...NSTEMI in a Patient With Diabetes and Multivessel Disease
RELEASE DATE: Sep 26, 2011
Arrhythmia/EP
Emerging Approaches to HF
Featured program
Optimal Implementation of Evidence-Based HF Therapies on Mortality
RELEASE DATE: Sep 07, 2011
Lipid/Metabolic
Residual Risk Management
Featured program
HDL-C in the Spotlight: Modulating CETP to Reduce Cardiovascular Risk
RELEASE DATE: Sep 19, 2011
Hypertension
Resistant Hypertension
Featured program
Bridging Treatment Gaps to Better Manage Resistant Hypertension
RELEASE DATE: Dec 09, 2011
Clinical cardiology
Stable Ischemic Heart Disease
Featured program
Tips for Enhancing Medical Therapy in Patients With SIDH
RELEASE DATE: May 17, 2011
Interventional/Surgery
Stents, Structure and Stenosis
Featured program
How Novel Stent Technology Improves Patient Outcomes
RELEASE DATE: Jun 28, 2011
Interventional Cardiology Live Case Study Series
Interventional Cardiology Live Case Study Series
On February 21, 2012, join Drs. Sharma, Kini and Mehta as they present advanced interventional techniques used in complex cases LIVE from Mt. Sinai's Cath Lab
View archived programs
Press center
Latest cardiology-related press releases and communications from industry
Poll
What will be the biggest story of 2012?
New anticoagulants
Renal nerve ablation
HDL-raising therapies
Transcatheter valves
Wireless/Remote monitoring

See: Biggest cardiology stories of 2011
Vote
Also on theheart.org
All about dronedarone, from ATHENA to PALLAS
Editorial series
All about dronedarone, from ATHENA to PALLAS
1 COMMENT - Jan 6, 2012 07:30 EST
Join Drs Melissa Walton-Shirley and Anne Gillis as they discuss the latest data on dronedarone and the impact for clinicians treating AF patients with significant structural heart disease.
AHA 2011 trials to treatments: ATLAS ACS2, TRACER, and MI FREEE
The Cardiology Show
AHA 2011 trials to treatments: ATLAS ACS2, TRACER, and MI FREEE
3 COMMENTS - Nov 16, 2011 14:30 EST
Dr Valentin Fuster sits down with Drs William Boden, John Chapman, Keith Fox, Anne Gillis, Jessica Mega, and Clyde Yancy to tackle the brave new world of antithrombotics and to ask whether academics have left the real world, and their patients, behind.